Filing Details

Accession Number:
0001144204-18-019836
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-09 19:36:47
Reporting Period:
2018-04-09
Accepted Time:
2018-04-09 19:36:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559569 Mark Pruzanski C/O Intercept Pharmaceuticals, Inc.,
10 Hudson Yards, Floor 37
New York NY 10001
Ceo & President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-09 7,812 $64.00 576,564 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct